T2 Biosystems
In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More
News items for the week of Jan. 23, 2023.
Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen
The genomic and diagnostics firms posted quarterly financial results late this week.
HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator.
T2 Biosystems Regains Compliance with Nasdaq Listing Requirement
The company had previously been informed that its shares failed to meet the exchange's $1 minimum bid price requirement.
Canaccord Downgrades T2 Biosystems to Hold
The investment bank cited a soft Q3 outlook, slower-than-expected pipeline progress, and capital and liquidity concerns raised in the company's preliminary quarterly results.
Aug 30, 2022
T2 Biosystems Regains Nasdaq Listing Requirements
Nov 4, 2021
T2 Biosystems Q3 Revenues Jump 42 Percent
May 7, 2021
May 6, 2021
T2 Biosystems Q1 Revenues Nearly Triple
Nov 4, 2020